Microenvironmental TFPI2 in Hirschsprung Disease: Mechanisms in ENCC Development
Topic overview
This research examines how tissue factor pathway inhibitor 2 (TFPI2) in the intestinal microenvironment may contribute to Hirschsprung disease pathogenesis by affecting enteric neural crest cell development. The study explores molecular mechanisms underlying defective ENCC colonization that leads to absent enteric ganglia in this common pediatric surgical condition.
Key takeaways
- Hirschsprung disease results from failed enteric neural crest cell (ENCC) colonization, leading to absent ganglion cells in the intestine.
- TFPI2 (tissue factor pathway inhibitor 2) in the intestinal microenvironment may play a pathogenic role in HSCR development.
- Understanding microenvironmental factors like TFPI2 could reveal novel therapeutic targets beyond current surgical management of HSCR.
- Defective ENCC migration and differentiation are central to HSCR pathophysiology, not just genetic mutations alone.
- Research into intestinal microenvironment alterations may explain variable HSCR phenotypes and guide personalized treatment approaches.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Microenvironmental TFPI2 in Hirschsprung Disease: Mechanisms in ENCC Development. GlobalCastMD Medical Library. 2025-08-30. https://library.globalcastmd.com/article/10920
Comments